• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血祖细胞激酶1在T细胞受体信号传导中的作用。

Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling.

作者信息

Ling P, Meyer C F, Redmond L P, Shui J W, Davis B, Rich R R, Hu M C, Wange R L, Tan T H

机构信息

Department of Immunology and the Interdepartmental Program in Cell and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.

出版信息

J Biol Chem. 2001 Jun 1;276(22):18908-14. doi: 10.1074/jbc.M101485200. Epub 2001 Mar 13.

DOI:10.1074/jbc.M101485200
PMID:11279207
Abstract

Hematopoietic progenitor kinase 1 (HPK1), a mammalian Ste20-related serine/threonine protein kinase, is a hematopoietic-specific upstream activator of the c-Jun N-terminal kinase. Here, we provide evidence to demonstrate the involvement of HPK1 in T cell receptor (TCR) signaling. HPK1 was activated and tyrosine-phosphorylated with similar kinetics following TCR/CD3 or pervanadate stimulation. Co-expression of protein-tyrosine kinases, Lck and Zap70, with HPK1 led to HPK1 activation and tyrosine phosphorylation in transfected mammalian cells. Upon TCR/CD3 stimulation, HPK1 formed inducible complexes with the adapters Nck and Crk with different kinetics, whereas it constitutively interacted with the adapters Grb2 and CrkL in Jurkat T cells. Interestingly, HPK1 also inducibly associated with linker for activation of T cells (LAT) through its proline-rich motif and translocated into glycolipid-enriched microdomains (also called lipid rafts) following TCR/CD3 stimulation, suggesting a critical role for LAT in the regulation of HPK1. Together, these results identify HPK1 as a new component of TCR signaling. T cell-specific signaling molecules Lck, Zap70, and LAT play roles in the regulation of HPK1 during TCR signaling. Differential complex formation between HPK1 and adapters highlights the possible involvement of HPK1 in multiple signaling pathways in T cells.

摘要

造血祖细胞激酶1(HPK1)是一种与哺乳动物Ste20相关的丝氨酸/苏氨酸蛋白激酶,是c-Jun氨基末端激酶的造血特异性上游激活剂。在此,我们提供证据证明HPK1参与T细胞受体(TCR)信号传导。TCR/CD3或过氧钒酸盐刺激后,HPK1以相似的动力学被激活并发生酪氨酸磷酸化。蛋白酪氨酸激酶Lck和Zap70与HPK1共表达导致转染的哺乳动物细胞中HPK1激活和酪氨酸磷酸化。TCR/CD3刺激后,HPK1与衔接蛋白Nck和Crk以不同的动力学形成诱导性复合物,而在Jurkat T细胞中它与衔接蛋白Grb2和CrkL组成性相互作用。有趣的是,HPK1还通过其富含脯氨酸的基序与T细胞激活衔接蛋白(LAT)诱导性结合,并在TCR/CD3刺激后转位到富含糖脂的微结构域(也称为脂筏),提示LAT在HPK1的调节中起关键作用。总之,这些结果确定HPK1是TCR信号传导的一个新组分。T细胞特异性信号分子Lck、Zap70和LAT在TCR信号传导过程中对HPK1的调节起作用。HPK1与衔接蛋白之间不同的复合物形成突出了HPK1可能参与T细胞中的多种信号通路。

相似文献

1
Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling.造血祖细胞激酶1在T细胞受体信号传导中的作用。
J Biol Chem. 2001 Jun 1;276(22):18908-14. doi: 10.1074/jbc.M101485200. Epub 2001 Mar 13.
2
Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinase.造血祖细胞激酶1与衔接蛋白Crk和CrkL的相互作用导致c-Jun氨基末端激酶的协同激活。
Mol Cell Biol. 1999 Feb;19(2):1359-68. doi: 10.1128/MCB.19.2.1359.
3
The adaptor protein Gads (Grb2-related adaptor downstream of Shc) is implicated in coupling hemopoietic progenitor kinase-1 to the activated TCR.衔接蛋白Gads(Shc下游与Grb2相关的衔接蛋白)参与将造血祖细胞激酶-1与活化的T细胞受体偶联。
J Immunol. 2000 Aug 1;165(3):1417-26. doi: 10.4049/jimmunol.165.3.1417.
4
The germinal center kinase (GCK)-related protein kinases HPK1 and KHS are candidates for highly selective signal transducers of Crk family adapter proteins.生发中心激酶(GCK)相关蛋白激酶HPK1和KHS是Crk家族衔接蛋白的高选择性信号转导分子的候选者。
Oncogene. 1998 Oct 15;17(15):1893-901. doi: 10.1038/sj.onc.1202108.
5
The SH3 domain-containing adaptor HIP-55 mediates c-Jun N-terminal kinase activation in T cell receptor signaling.含SH3结构域的衔接蛋白HIP-55在T细胞受体信号传导中介导c-Jun氨基末端激酶激活。
J Biol Chem. 2003 Dec 26;278(52):52195-202. doi: 10.1074/jbc.M305026200. Epub 2003 Oct 13.
6
SH2/SH3 adaptor proteins can link tyrosine kinases to a Ste20-related protein kinase, HPK1.SH2/SH3衔接蛋白可将酪氨酸激酶与一种Ste20相关蛋白激酶HPK1连接起来。
J Biol Chem. 1997 Oct 31;272(44):27804-11. doi: 10.1074/jbc.272.44.27804.
7
HPK1 is activated by lymphocyte antigen receptors and negatively regulates AP-1.HPK1 被淋巴细胞抗原受体激活,并对 AP-1 进行负调控。
Immunity. 2000 Apr;12(4):399-408. doi: 10.1016/s1074-7613(00)80192-2.
8
Roles of Lck, Syk and ZAP-70 tyrosine kinases in TCR-mediated phosphorylation of the adapter protein Shc.Lck、Syk和ZAP-70酪氨酸激酶在T细胞受体介导的衔接蛋白Shc磷酸化中的作用。
Eur J Immunol. 1998 Aug;28(8):2265-75. doi: 10.1002/(SICI)1521-4141(199808)28:08<2265::AID-IMMU2265>3.0.CO;2-P.
9
Crk adaptor proteins regulate CD3ζ chain phosphorylation and TCR/CD3 down-modulation in activated T cells.Crk衔接蛋白调节活化T细胞中CD3ζ链的磷酸化及TCR/CD3的下调。
Cell Signal. 2017 Aug;36:117-126. doi: 10.1016/j.cellsig.2017.04.022. Epub 2017 Apr 29.
10
Membrane raft-dependent regulation of phospholipase Cgamma-1 activation in T lymphocytes.T淋巴细胞中膜筏依赖性对磷脂酶Cγ-1激活的调节
Mol Cell Biol. 2001 Oct;21(20):6939-50. doi: 10.1128/MCB.21.20.6939-6950.2001.

引用本文的文献

1
Synthetic chemistry enabling the discovery and development of a series of pyrazoles as HPK1 inhibitors.合成化学助力一系列吡唑类化合物作为HPK1抑制剂的发现与开发。
RSC Med Chem. 2025 May 27. doi: 10.1039/d5md00309a.
2
HPK1 kinase inhibitor: a sufficient approach to target HPK1 to modulate T cell activation in cancer immunotherapy compared with degraders.HPK1激酶抑制剂:与降解剂相比,靶向HPK1以调节癌症免疫治疗中T细胞活化的一种有效方法。
Front Immunol. 2025 Feb 6;16:1449106. doi: 10.3389/fimmu.2025.1449106. eCollection 2025.
3
An updated review of small-molecule HPK1 kinase inhibitors (2016-present).
小分子HPK1激酶抑制剂的最新综述(2016年至今)。
Future Med Chem. 2024;16(22):2431-2450. doi: 10.1080/17568919.2024.2420630. Epub 2024 Nov 25.
4
Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer.BAY-405 的发现:一种基于氮杂吲哚的 MAP4K1 抑制剂,用于增强 T 细胞对癌症的免疫反应。
J Med Chem. 2024 Oct 10;67(19):17429-17453. doi: 10.1021/acs.jmedchem.4c01325. Epub 2024 Sep 27.
5
HPK1 Dysregulation-Associated NK Cell Dysfunction and Defective Expansion Promotes Metastatic Melanoma Progression.HPK1 失调相关的 NK 细胞功能障碍和缺陷性扩增促进转移性黑色素瘤进展。
Adv Sci (Weinh). 2024 Aug;11(29):e2400920. doi: 10.1002/advs.202400920. Epub 2024 Jun 3.
6
Small molecule inhibitors for cancer immunotherapy and associated biomarkers - the current status.小分子抑制剂在癌症免疫治疗及相关生物标志物中的应用现状。
Front Immunol. 2023 Oct 31;14:1297175. doi: 10.3389/fimmu.2023.1297175. eCollection 2023.
7
Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets.T 细胞受体(TCR)信号的负性细胞内调节剂作为潜在的抗肿瘤免疫治疗靶点。
J Immunother Cancer. 2023 May;11(5). doi: 10.1136/jitc-2022-005845.
8
Theoretical Studies on Selectivity of HPK1/JAK1 Inhibitors by Molecular Dynamics Simulations and Free Energy Calculations.基于分子动力学模拟和自由能计算的 HPK1/JAK1 抑制剂选择性的理论研究。
Int J Mol Sci. 2023 Jan 31;24(3):2649. doi: 10.3390/ijms24032649.
9
Association of miR-499 Polymorphism and Its Regulatory Networks with Hashimoto Thyroiditis Susceptibility: A Population-Based Case-Control Study.miR-499 多态性及其调控网络与桥本甲状腺炎易感性的关联:一项基于人群的病例对照研究。
Int J Mol Sci. 2021 Sep 18;22(18):10094. doi: 10.3390/ijms221810094.
10
Identification of Potent Reverse Indazole Inhibitors for HPK1.HPK1强效反向吲唑抑制剂的鉴定
ACS Med Chem Lett. 2021 Mar 1;12(3):459-466. doi: 10.1021/acsmedchemlett.0c00672. eCollection 2021 Mar 11.